American International Group’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-20,337
Closed -$37.6K 3257
2023
Q1
$37.6K Buy
20,337
+405
+2% +$749 ﹤0.01% 2785
2022
Q4
$22.1K Sell
19,932
-72
-0.4% -$80 ﹤0.01% 2913
2022
Q3
$47K Buy
20,004
+282
+1% +$663 ﹤0.01% 2831
2022
Q2
$60K Buy
19,722
+3,355
+20% +$10.2K ﹤0.01% 2820
2022
Q1
$111K Sell
16,367
-1,152
-7% -$7.81K ﹤0.01% 2555
2021
Q4
$146K Sell
17,519
-524
-3% -$4.37K ﹤0.01% 2547
2021
Q3
$134K Sell
18,043
-429
-2% -$3.19K ﹤0.01% 2660
2021
Q2
$126 Buy
18,472
+8,415
+84% +$57 ﹤0.01% 2783
2021
Q1
$103 Buy
10,057
+27
+0.3% ﹤0.01% 2707
2020
Q4
$70 Sell
10,030
-288
-3% -$2 ﹤0.01% 2838
2020
Q3
$84K Sell
10,318
-235
-2% -$1.91K ﹤0.01% 2623
2020
Q2
$73K Buy
10,553
+975
+10% +$6.75K ﹤0.01% 2717
2020
Q1
$45K Sell
9,578
-554
-5% -$2.6K ﹤0.01% 2728
2019
Q4
$88K Sell
10,132
-84
-0.8% -$730 ﹤0.01% 2700
2019
Q3
$34K Sell
10,216
-72
-0.7% -$240 ﹤0.01% 2969
2019
Q2
$51K Buy
10,288
+234
+2% +$1.16K ﹤0.01% 2939
2019
Q1
$62K Sell
10,054
-326
-3% -$2.01K ﹤0.01% 2807
2018
Q4
$35K Sell
10,380
-80
-0.8% -$270 ﹤0.01% 2958
2018
Q3
$68K Buy
10,460
+189
+2% +$1.23K ﹤0.01% 2987
2018
Q2
$79K Buy
10,271
+1,018
+11% +$7.83K ﹤0.01% 2883
2018
Q1
$207K Sell
9,253
-499
-5% -$11.2K ﹤0.01% 2246
2017
Q4
$124K Buy
9,752
+193
+2% +$2.45K ﹤0.01% 2615
2017
Q3
$149K Buy
9,559
+5,442
+132% +$84.8K ﹤0.01% 2450
2017
Q2
$58K Buy
+4,117
New +$58K ﹤0.01% 2966